- with Synthélabo in 1999 to form
Sanofi-Synthélabo. In 2004,
Sanofi-Synthélabo
merged with
Aventis and
renamed to
Sanofi-Aventis,
which were each the product...
- 8437°E / 45.727; 4.8437
Sanofi Pasteur is the
vaccines division of the
French multinational pharmaceutical company Sanofi.
Sanofi Pasteur is the largest...
- The
Sanofi–GSK COVID-19 vaccine, sold
under the
brand name
VidPrevtyn Beta, is a COVID-19
vaccine developed by
Sanofi Pasteur and GSK. The
Sanofi–GSK...
-
Amgen Inc. v.
Sanofi, 598 U.S. 594 (2023), is a
United States Supreme Court case in
which the
Court held that Amgen's two
patent applications on cholesterol-lowering...
- De****n (
Sanofi S.R.L. Italy) De****ne (
Sanofi Aventis France) De****ne (
Sanofi Synthelabo Romania)
Depalept (
Sanofi Aventis Israel)
Deprakine (
Sanofi Aventis...
- With the new company's 2004
merger with
Sanofi-Synthélabo, it
became a
subsidiary of the
resulting Sanofi-Aventis
pharmaceuticals group. The company...
- 2020" (PDF). "
Sanofi Form 20-F 2019" (PDF). "
Sanofi Form 20-F 2018" (PDF). "
Sanofi Form 20-F 2017" (PDF). "
Sanofi Form 20-F 2016" (PDF). "
Sanofi Form 20-F...
- The
Sanofi–Translate Bio COVID-19 vaccine, also
known as MRT5500 or VAW00001, was a COVID-19
vaccine candidate developed by
Sanofi Pasteur and Translate...
- –
Sankyo Pharma UK Ltd
Sanofi-Aventis –
Sanofi-Aventis Ltd
Sanofi Pasteur –
Sanofi Pasteur MSD Ltd
Sanofi-Synthélabo –
Sanofi-Aventis Ltd Schering-Plough...
- inflammation.[citation needed] On
March 26, 2012,
Bloomberg announced that
Sanofi and
Regeneron were in
development of a new drug that
would help
reduce cholesterol...
